"The team at Laminar is driven by our vision to develop and deliver an innovative solution to help patients live without the fear of stroke, or the need for long-term use of blood thinners,” Lamar President and CEO Randy Lashinski said about the company's technology.
Located in the site of a former Sears store that closed in 2020, the 166,000-square-foot, three-story building is the health network’s largest outpatient facility to date.
The Woodcliff Lake-based company has named Chairman of the Board Michael Graves as interim executive chairman of the board and interim principal executive officer.
The New Jersey Devils and RWJBarnabas Health recently hosted Hockey Fights Cancer Night at Prudential Center and gave 13-year-old Charlie Shomers a gameday experience like no other.
The publication evaluated more than 15,000 facilities across the nation, with a total of 2,804 centers earning the highest marks for either or both short- and long-term care.
The conference’s keynote address was given by Adam Taliaferro, J&J’s director of state and community engagement and a former Penn State football player who suffered a career-ending spinal cord injury and is now an advocate for individuals with disabilities.
As it did in a September announcement, the East Hanover-based drugmaker said crystal formation in some bottles of its Sandimmune Oral Solution could potentially lead to incorrect dosing.
Kathleen Jacobs will join the state’s largest academic health system from New York University, where she held the same title for the past eight years.
The Secaucus-based diagnostics company “is continually exploring opportunities to serve large unmet clinical needs with new innovations, developed both organically and with third parties," according to Vice President and General Manager, Oncology, Kristie Dolan.
The facility at Hackensack Meridian Jersey Shore University Medical Center in Neptune belongs to the newly renamed ALS United Mid-Atlantic.
The Cambridge, Mass.-based target works on treatments for neurodegenerative and rare diseases, including Parkinson's disease and ALS.
J&J did not say how many cases the resolution covered but told NJBIZ it is “in furtherance of our stated goal of achieving a complete, equitable and efficient resolution of the talc litigation.”